UBS Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.79M | Buy |
99,624
+47,085
| +90% | +$2.17M | ﹤0.01% | 3913 |
|
|
2025
Q4 | $2.35M | Sell |
52,539
-54,205
| -51% | -$2.28M | ﹤0.01% | 4818 |
|
|
2025
Q3 | $4.29M | Sell |
106,744
-46,314
| -30% | -$1.63M | ﹤0.01% | 4195 |
|
|
2025
Q2 | $4.79M | Buy |
153,058
+47,725
| +45% | +$1.56M | ﹤0.01% | 3938 |
|
|
2025
Q1 | $3.53M | Buy |
105,333
+98,628
| +1,471% | +$3.74M | ﹤0.01% | 4149 |
|
|
2024
Q4 | $263K | Sell |
6,705
-6,585
| -50% | -$272K | ﹤0.01% | 6288 |
|
|
2024
Q3 | $523K | Buy |
13,290
+712
| +6% | +$28.7K | ﹤0.01% | 5193 |
|
|
2024
Q2 | $490K | Sell |
12,578
-23,668
| -65% | -$946K | ﹤0.01% | 5021 |
|
|
2024
Q1 | $1.56M | Buy |
36,246
+5,303
| +17% | +$244K | ﹤0.01% | 4189 |
|
|
2023
Q4 | $1.43M | Buy |
30,943
+25,061
| +426% | +$885K | ﹤0.01% | 4171 |
|
|
2023
Q3 | $201K | Buy |
5,882
+1,003
| +21% | +$37.5K | ﹤0.01% | 5382 |
|
|
2023
Q2 | $188K | Buy |
4,879
+265
| +6% | +$10.5K | ﹤0.01% | 5523 |
|
|
2023
Q1 | $165K | Sell |
4,614
-48
| -1% | -$1.77K | ﹤0.01% | 5537 |
|
|
2022
Q4 | $184K | Buy |
4,662
+1,236
| +36% | +$45K | ﹤0.01% | 5530 |
|
|
2022
Q3 | $123K | Buy |
3,426
+954
| +39% | +$34.3K | ﹤0.01% | 5526 |
|
|
2022
Q2 | $76K | Buy |
2,472
+1,249
| +102% | +$37.8K | ﹤0.01% | 5625 |
|
|
2022
Q1 | $38K | Sell |
1,223
-554
| -31% | -$16.6K | ﹤0.01% | 6769 |
|
|
2021
Q4 | $56K | Buy |
1,777
+755
| +74% | +$22.6K | ﹤0.01% | 6801 |
|
|
2021
Q3 | $16K | Buy |
1,022
+1
| +0.1% | +$17 | ﹤0.01% | 7436 |
|
|
2021
Q2 | $19K | Buy |
1,021
+21
| +2% | +$387 | ﹤0.01% | 7406 |
|
|
2021
Q1 | $18K | Sell |
1,000
-722
| -42% | -$12.2K | ﹤0.01% | 7478 |
|
|
2020
Q4 | $27K | Sell |
1,722
-264
| -13% | -$3.09K | ﹤0.01% | 6728 |
|
|
2020
Q3 | $22K | Sell |
1,986
-288
| -13% | -$3.39K | ﹤0.01% | 6250 |
|
|
2020
Q2 | $29K | Buy |
2,274
+1,642
| +260% | +$20.9K | ﹤0.01% | 6305 |
|
|
2020
Q1 | $7K | Sell |
632
-1,121
| -64% | -$16K | ﹤0.01% | 7164 |
|
|
2019
Q4 | $23K | Buy |
1,753
+522
| +42% | +$5.49K | ﹤0.01% | 6797 |
|
|
2019
Q3 | $11K | Sell |
1,231
-3,892
| -76% | -$36.8K | ﹤0.01% | 7120 |
|
|
2019
Q2 | $51K | Buy |
5,123
+2,123
| +71% | +$20.3K | ﹤0.01% | 5915 |
|
|
2019
Q1 | $30K | Buy |
3,000
+2,851
| +1,913% | +$24.2K | ﹤0.01% | 5951 |
|
|
2018
Q4 | $1K | Sell |
149
-705
| -83% | -$6.26K | ﹤0.01% | 7924 |
|
|
2018
Q3 | $11K | Sell |
854
-35
| -4% | -$406 | ﹤0.01% | 7123 |
|
|
2018
Q2 | $8K | Buy |
+889
| New | +$5.52K | ﹤0.01% | 7280 |
|
|
2017
Q3 | – | Sell |
-2,530
| Closed | -$8K | – | 8036 |
|
|
2017
Q2 | $8K | Buy |
+2,530
| New | +$9.89K | ﹤0.01% | 6928 |
|
|
2016
Q4 | – | Sell |
-617
| Closed | -$5K | – | 8077 |
|
|
2016
Q3 | $5K | Buy |
+617
| New | +$4.77K | ﹤0.01% | 7137 |
|
|
2016
Q2 | – | Sell |
-1,106
| Closed | -$8K | – | 8009 |
|
|
2016
Q1 | $8K | Sell |
1,106
-1,523
| -58% | -$10.9K | ﹤0.01% | 6801 |
|
|
2015
Q4 | $21K | Buy |
+2,629
| New | +$22.5K | ﹤0.01% | 6724 |
|
|
2015
Q3 | – | Sell |
-1,058
| Closed | -$12K | – | 8665 |
|
|
2015
Q2 | $12K | Buy |
1,058
+712
| +206% | +$9.84K | ﹤0.01% | 7323 |
|
|
2015
Q1 | $6K | Sell |
346
-26
| -7% | -$480 | ﹤0.01% | 8021 |
|
|
2014
Q4 | $7K | Buy |
+372
| New | +$5.46K | ﹤0.01% | 8730 |
|
Other funds holding XENE
ACA
DCM
PCH
